Astatine-211 labeled chimeric anti-tenascin antibody: Phase I trial in brain tumor resection cavity patients

Journal Article

Full Text

Duke Authors

Cited Authors

  • Zalutsky, MR; Akabani, G; Cokgor, I; Friedman, HS; Coleman, RE; Friedman, AH; McLendon, RE; Bigner, DD

Published Date

  • September 1999

Published In

Volume / Issue

  • 26 / 9

Start / End Page

  • 1215 - 1215

International Standard Serial Number (ISSN)

  • 0340-6997